BACKGROUND: The recently identified autonomous mouse parvovirus designated mouse parvovirus-1 (MPV-1) persists in adult BALB/c mice for at least 9 weeks, infects lymphoid tissues, interferes with the ability of cloned T cells to proliferate, and exhibits immunomodulatory properties. As a consequence of these findings, the present studies were undertaken to characterize further the inmunomodulatory effects of MPV-1 on T cell-mediated immune responses in vivo and in vitro. METHODS: To evaluate the effect of MPV-1 infection on CD8+ T cell-mediated responses, BALB/c-H2dm2 mice were infected after transplantation of allogeneic BALB/c skin. RESULTS: MPV-1 potentiated the rejection of allogeneic skin grafts. This potentiation was not a result of virus infecting the cellular or vascular component of the graft as determined by in situ hybridization, but was mediated by T cells. However, the proliferative capacity of alloantigen-reactive lymphocytes from graft-sensitized infected mice was diminished. MPV-1 also induced the rejection of syngeneic skin grafts, and T cells from these infected graft-sensitized mice lysed syngeneic P815 target cells. CONCLUSIONS: These results suggest that MPV-1 infection of skin-grafted mice may disrupt normal mechanisms of peripheral tolerance and provide a unique model to study virus-induced autoimmunity.
BACKGROUND: The recently identified autonomous mouse parvovirus designated mouse parvovirus-1 (MPV-1) persists in adult BALB/c mice for at least 9 weeks, infects lymphoid tissues, interferes with the ability of cloned T cells to proliferate, and exhibits immunomodulatory properties. As a consequence of these findings, the present studies were undertaken to characterize further the inmunomodulatory effects of MPV-1 on T cell-mediated immune responses in vivo and in vitro. METHODS: To evaluate the effect of MPV-1 infection on CD8+ T cell-mediated responses, BALB/c-H2dm2 mice were infected after transplantation of allogeneic BALB/c skin. RESULTS:MPV-1 potentiated the rejection of allogeneic skin grafts. This potentiation was not a result of virus infecting the cellular or vascular component of the graft as determined by in situ hybridization, but was mediated by T cells. However, the proliferative capacity of alloantigen-reactive lymphocytes from graft-sensitized infected mice was diminished. MPV-1 also induced the rejection of syngeneic skin grafts, and T cells from these infected graft-sensitized mice lysed syngeneic P815 target cells. CONCLUSIONS: These results suggest that MPV-1 infection of skin-grafted mice may disrupt normal mechanisms of peripheral tolerance and provide a unique model to study virus-induced autoimmunity.
Authors: James D Macy; Gail A Cameron; Peter C Smith; Tracy A Ferguson; Susan R Compton Journal: J Am Assoc Lab Anim Sci Date: 2011-07 Impact factor: 1.232
Authors: Kenneth S Henderson; Kathleen R Pritchett-Corning; Cheryl L Perkins; Laila A Banu; Steven M Jennings; Brian C Francis; William R Shek Journal: Comp Med Date: 2015-02 Impact factor: 0.982
Authors: Lisa J Ball-Goodrich; Frank X Paturzo; Elizabeth A Johnson; Krista Steger; Robert O Jacoby Journal: J Virol Date: 2002-10 Impact factor: 5.103
Authors: Robert S Livingston; David G Besselsen; Earl K Steffen; Cynthia L Besch-Williford; Craig L Franklin; Lela K Riley Journal: Clin Diagn Lab Immunol Date: 2002-09
Authors: David G Besselsen; Erin L Myers; Craig L Franklin; Scott W Korte; April M Wagner; Kenneth S Henderson; Benjamin J Weigler Journal: Comp Med Date: 2008-04 Impact factor: 0.982
Authors: David G Besselsen; Melissa J Romero-Aleshire; Stephanie J Munger; Emily C Marcus; Kenneth S Henderson; April M Wagner Journal: Comp Med Date: 2008-08 Impact factor: 0.982